Product
Imipenem/Cilastatin
Aliases
XNW4107, Imipenem/Cilastatin
3 clinical trials
6 indications
Indication
Bacterial InfectionsIndication
Acinetobacter baumanniiIndication
Hospital-acquired Bacterial PneumoniaIndication
Ventilator-associated PneumoniaIndication
BacteremiaIndication
Colistin Resistant ABCClinical trial
A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF XNW4107, IMIPENEM AND CILASTATIN ADMINISTERED CONCURRENTLY AS INTRAVENOUS INFUSION TO SUBJECTS WITH VARIOUS DEGREES OF RENAL FUNCTIONStatus: Completed, Estimated PCD: 2021-10-30
Clinical trial
A Randomized, Active-controlled Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus ComplexStatus: Completed, Estimated PCD: 2021-07-26
Clinical trial
A Phase 1, Single-Dose, Randomized, Double Blind, Placebo-Controlled Study to Evaluate Pharmacokinetics, Safety and Tolerability of XNW4107 for Injection in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females.Status: Completed, Estimated PCD: 2021-10-30